Antibiofilm activity of Heather and Manuka honeys and antivirulence potential of some of their constituents on the DsbA1 enzyme of Pseudomonas aeruginosa
Shirlaw, Oscar and Billah, Zara and Attar, Baraa and Hughes, Lisa and Qasaymeh, Rana M. and Seidel, Veronique and Efthimiou, Georgios (2020) Antibiofilm activity of Heather and Manuka honeys and antivirulence potential of some of their constituents on the DsbA1 enzyme of Pseudomonas aeruginosa. Antibiotics, 9 (12). 911. (https://doi.org/10.3390/antibiotics9120911)
Preview |
Text.
Filename: Shirlaw_etal_Antibiotics_2020_Antibiofilm_activity_of_heather_and_Manuka_honeys_and_antivirulence_potential.pdf
Final Published Version License: Download (722kB)| Preview |
Abstract
Heather honey was tested for its effect on the formation of biofilms by Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, Enterococcus faecalis, Salmonella Enteriditis and Acinetobacter baumanii in comparison with Manuka honey. At 0.25 mg/mL, Heather honey inhibited biofilm formation in S. aureus, A. baumanii, E. coli, S. Enteriditis and P. aeruginosa, but promoted the growth of E. faecalis and K. pneumoniae biofilms. Manuka honey inhibited biofilm formation in K. pneumoniae, E. faecalis, and S. Enteriditis, A. baumanii, E. coli and P. aeruginosa, but promoted S. aureus biofilm formation. Molecular docking with Autodock Vina was performed to calculate the predictive binding affinities and ligand efficiencies of Manuka and Heather honey constituents for PaDsbA1, the main enzyme controlling the correct folding of virulence proteins in Pseudomonas aeruginosa. A number of constituents, including benzoic acid and methylglyoxal, present in Heather and/or Manuka honey, revealed high ligand efficiencies for the target enzyme. This helps support, to some extent, the decrease in P. aeruginosa biofilm formation observed for such honeys.
ORCID iDs
Shirlaw, Oscar, Billah, Zara, Attar, Baraa, Hughes, Lisa, Qasaymeh, Rana M., Seidel, Veronique ORCID: https://orcid.org/0000-0003-3880-5261 and Efthimiou, Georgios;-
-
Item type: Article ID code: 74895 Dates: DateEvent15 December 2020Published10 December 2020AcceptedSubjects: Medicine > Therapeutics. Pharmacology Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences Depositing user: Pure Administrator Date deposited: 15 Dec 2020 14:59 Last modified: 11 Nov 2024 12:55 URI: https://strathprints.strath.ac.uk/id/eprint/74895